CPXX Insider Trading Activity and SEC Form 4 Filings
CPXX insider trading summary
No open-market insider purchases or sales of Celator Pharmaceuticals Inc (CPXX) have been reported on SEC Form 4 in the past 12 months.
Latest CPXX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 3, 2015 | Scott D Morenstein | Director | Buy | $9K (5,000 @ $1.86) |
| Oct 6, 2015 | Scott Thomas Jackson | Chief Executive Officer | Buy | $25K (14,450 @ $1.74) |
| Oct 5, 2015 | Fred M Powell | VP and Chief Financial Officer | Buy | $24K (13,700 @ $1.78) |
| Oct 1, 2015 | Valence CDK SPV, L.P. | Insider | Buy | $3K (2,000 @ $1.64) |
| Oct 1, 2015 | Valence Life Sciences GP II LLC | Insider | Buy | $3K (2,000 @ $1.64) |
| Oct 1, 2015 | Eric W Roberts | Insider | Buy | $3K (2,000 @ $1.64) |
| Sep 30, 2015 | Valence Life Sciences GP II LLC | Insider | Buy | $5K (3,000 @ $1.66) |
| Sep 30, 2015 | Valence CDK SPV, L.P. | Insider | Buy | $334 (200 @ $1.67) |
| Sep 30, 2015 | Eric W Roberts | Insider | Buy | $5K (3,000 @ $1.66) |
| Sep 30, 2015 | Eric W Roberts | Insider | Buy | $334 (200 @ $1.67) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.